Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine

Objectives: Evaluate the efficacy and tolerability of itraconazole plus terbinafine for refractory onychomycosis. This is a prospective clinical trial. Patients with proven Trychophyton rubrum onychomycosis of toenails were enrolled; the treatment consisted of weekly administration: itraconazole 200...

Full description

Bibliographic Details
Main Authors: Bonifaz Alexandro, Vázquez-González Denisse, Saúl Amado, Fierro-Arias Leonel, Ponce-Olivera M. Rosa
Format: Article
Language:English
Published: Our Dermatology Online 2011-07-01
Series:Nasza Dermatologia Online
Subjects:
Online Access:http://odermatol.like.pl/upload/file/2_Refractory%20onychomycosis.pdf
id doaj-4aca4dd2412f49c5b638dcd12acebb51
record_format Article
spelling doaj-4aca4dd2412f49c5b638dcd12acebb512020-11-24T22:50:12ZengOur Dermatology OnlineNasza Dermatologia Online2081-93902011-07-0123108112Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafineBonifaz AlexandroVázquez-González DenisseSaúl AmadoFierro-Arias LeonelPonce-Olivera M. RosaObjectives: Evaluate the efficacy and tolerability of itraconazole plus terbinafine for refractory onychomycosis. This is a prospective clinical trial. Patients with proven Trychophyton rubrum onychomycosis of toenails were enrolled; the treatment consisted of weekly administration: itraconazole 200mg/day and terbinafine 250mg/day, for four months. Results: Thirty-two patients with onychomycosis were studied. Twenty-eight cases had distal subungual onychomycosis and 4 total dystrophic onychomycosis. At the end of the follow-up 17/32 patients had clinical and mycologic cure (53.12%), 5 had clinical improvement only (15.6%), and 10 (31.2%) failed. Conclusion: Weekly alternate therapy with itraconazole + terbinafine represents a safe rescue treatment.http://odermatol.like.pl/upload/file/2_Refractory%20onychomycosis.pdfonychomycosisrefractorydistal subungual onychomycosisitraconazoleterbinafineTrichophyton rubrum
collection DOAJ
language English
format Article
sources DOAJ
author Bonifaz Alexandro
Vázquez-González Denisse
Saúl Amado
Fierro-Arias Leonel
Ponce-Olivera M. Rosa
spellingShingle Bonifaz Alexandro
Vázquez-González Denisse
Saúl Amado
Fierro-Arias Leonel
Ponce-Olivera M. Rosa
Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
Nasza Dermatologia Online
onychomycosis
refractory
distal subungual onychomycosis
itraconazole
terbinafine
Trichophyton rubrum
author_facet Bonifaz Alexandro
Vázquez-González Denisse
Saúl Amado
Fierro-Arias Leonel
Ponce-Olivera M. Rosa
author_sort Bonifaz Alexandro
title Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
title_short Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
title_full Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
title_fullStr Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
title_full_unstemmed Refractory onychomycosis due to Trichophyton rubrum: combination therapy with itraconazole and terbinafine
title_sort refractory onychomycosis due to trichophyton rubrum: combination therapy with itraconazole and terbinafine
publisher Our Dermatology Online
series Nasza Dermatologia Online
issn 2081-9390
publishDate 2011-07-01
description Objectives: Evaluate the efficacy and tolerability of itraconazole plus terbinafine for refractory onychomycosis. This is a prospective clinical trial. Patients with proven Trychophyton rubrum onychomycosis of toenails were enrolled; the treatment consisted of weekly administration: itraconazole 200mg/day and terbinafine 250mg/day, for four months. Results: Thirty-two patients with onychomycosis were studied. Twenty-eight cases had distal subungual onychomycosis and 4 total dystrophic onychomycosis. At the end of the follow-up 17/32 patients had clinical and mycologic cure (53.12%), 5 had clinical improvement only (15.6%), and 10 (31.2%) failed. Conclusion: Weekly alternate therapy with itraconazole + terbinafine represents a safe rescue treatment.
topic onychomycosis
refractory
distal subungual onychomycosis
itraconazole
terbinafine
Trichophyton rubrum
url http://odermatol.like.pl/upload/file/2_Refractory%20onychomycosis.pdf
work_keys_str_mv AT bonifazalexandro refractoryonychomycosisduetotrichophytonrubrumcombinationtherapywithitraconazoleandterbinafine
AT vazquezgonzalezdenisse refractoryonychomycosisduetotrichophytonrubrumcombinationtherapywithitraconazoleandterbinafine
AT saulamado refractoryonychomycosisduetotrichophytonrubrumcombinationtherapywithitraconazoleandterbinafine
AT fierroariasleonel refractoryonychomycosisduetotrichophytonrubrumcombinationtherapywithitraconazoleandterbinafine
AT ponceoliveramrosa refractoryonychomycosisduetotrichophytonrubrumcombinationtherapywithitraconazoleandterbinafine
_version_ 1725673483253317632